Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (633)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
276
13.170
 Why?
Papillomavirus Infections
19
2025
168
2.960
 Why?
Ovarian Neoplasms
37
2024
450
2.810
 Why?
Endometrial Neoplasms
34
2019
137
2.420
 Why?
Uterine Cervical Dysplasia
16
2017
49
2.410
 Why?
Carcinoma, Squamous Cell
31
2018
326
2.020
 Why?
Gene Expression Regulation, Neoplastic
19
2025
833
1.920
 Why?
Human papillomavirus 16
8
2019
44
1.720
 Why?
Papillomaviridae
17
2025
103
1.610
 Why?
Female
191
2025
27081
1.590
 Why?
Gene Expression Profiling
9
2021
1025
1.540
 Why?
DNA Methylation
22
2025
550
1.340
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
1000
1.300
 Why?
Genital Neoplasms, Female
10
2018
41
1.190
 Why?
Human papillomavirus 18
5
2019
9
1.170
 Why?
Humans
192
2025
50503
1.160
 Why?
Genetic Predisposition to Disease
13
2024
511
1.120
 Why?
Adult
92
2024
13577
1.090
 Why?
Neoplasm Staging
41
2019
746
1.030
 Why?
Middle Aged
99
2024
12611
1.030
 Why?
Adenocarcinoma
18
2018
397
1.000
 Why?
Polymorphism, Single Nucleotide
10
2019
475
0.970
 Why?
MicroRNAs
7
2019
344
0.950
 Why?
Fluorodeoxyglucose F18
15
2022
189
0.950
 Why?
DNA-Binding Proteins
9
2021
418
0.940
 Why?
Neoplasm Recurrence, Local
19
2024
629
0.930
 Why?
Carcinoma
12
2010
137
0.900
 Why?
Oncogene Proteins, Viral
4
2019
52
0.850
 Why?
Radiopharmaceuticals
14
2022
204
0.800
 Why?
Cervix Uteri
7
2017
42
0.800
 Why?
Repressor Proteins
4
2019
148
0.790
 Why?
Alphapapillomavirus
1
2021
13
0.750
 Why?
DNA, Viral
6
2019
136
0.740
 Why?
Cell Line, Tumor
18
2021
1398
0.730
 Why?
Immunologic Factors
2
2014
111
0.710
 Why?
Neoplasm Invasiveness
15
2020
269
0.690
 Why?
Neoplasms
8
2022
1251
0.680
 Why?
Genetic Markers
8
2017
104
0.670
 Why?
Genes, Tumor Suppressor
8
2007
73
0.670
 Why?
Neoplasm Proteins
10
2019
320
0.660
 Why?
Aged
70
2024
9741
0.660
 Why?
Immunoglobulins
3
2017
81
0.650
 Why?
Genomics
4
2018
279
0.630
 Why?
Gene Silencing
5
2018
115
0.620
 Why?
Biomedical Research
1
2022
244
0.620
 Why?
Vascular Endothelial Growth Factor A
2
2017
182
0.550
 Why?
Cisplatin
7
2022
286
0.550
 Why?
Proteomics
1
2019
314
0.540
 Why?
Aged, 80 and over
36
2024
3226
0.530
 Why?
Promoter Regions, Genetic
12
2020
465
0.520
 Why?
HLA-C Antigens
2
2018
4
0.520
 Why?
Receptors, KIR
2
2018
13
0.510
 Why?
Positron-Emission Tomography
11
2013
292
0.500
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.490
 Why?
Tumor Virus Infections
4
2006
47
0.490
 Why?
Lymph Nodes
10
2010
257
0.490
 Why?
Alleles
6
2025
256
0.490
 Why?
Microsatellite Repeats
14
2007
37
0.490
 Why?
Disease-Free Survival
17
2013
444
0.480
 Why?
Hysterectomy
15
2022
88
0.480
 Why?
Gynecologic Surgical Procedures
4
2010
29
0.480
 Why?
Virus Integration
3
2025
9
0.470
 Why?
Granulosa Cell Tumor
2
2024
2
0.460
 Why?
Phenotype
4
2016
739
0.450
 Why?
Prognosis
19
2021
1978
0.450
 Why?
Lymphatic Metastasis
14
2019
222
0.440
 Why?
Chromosomes, Human, Pair 6
4
2007
14
0.440
 Why?
Immunohistochemistry
13
2024
957
0.430
 Why?
Nuclear Proteins
8
2009
238
0.430
 Why?
Loss of Heterozygosity
10
2007
75
0.430
 Why?
Ovary
2
2008
103
0.410
 Why?
Membrane Proteins
3
2005
332
0.400
 Why?
Genotype
9
2018
533
0.400
 Why?
STAT3 Transcription Factor
3
2021
77
0.390
 Why?
Survival Analysis
14
2021
661
0.390
 Why?
Cell Movement
5
2021
247
0.390
 Why?
Ultrasonic Therapy
3
2001
34
0.380
 Why?
Peritoneal Neoplasms
4
2008
63
0.380
 Why?
Carcinoma, Endometrioid
6
2014
38
0.380
 Why?
Genes, p53
2
2010
49
0.380
 Why?
Cell Proliferation
6
2021
985
0.370
 Why?
Risk Factors
13
2019
3724
0.360
 Why?
Signal Transduction
8
2021
1624
0.360
 Why?
Uterine Neoplasms
5
2009
60
0.360
 Why?
Mutation
12
2018
1280
0.360
 Why?
Ascites
2
2008
28
0.350
 Why?
Carboplatin
2
2009
54
0.350
 Why?
Antineoplastic Agents
9
2014
1172
0.350
 Why?
Antibodies, Monoclonal
5
2021
462
0.350
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.340
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
11
0.340
 Why?
Cohort Studies
13
2024
1452
0.340
 Why?
Disease Progression
6
2020
829
0.340
 Why?
Base Sequence
8
2019
639
0.340
 Why?
GTPase-Activating Proteins
1
2009
23
0.340
 Why?
Membrane Glycoproteins
2
2009
245
0.330
 Why?
DNA, Neoplasm
11
2006
143
0.330
 Why?
Chromosomes, Human, Pair 11
3
2005
49
0.330
 Why?
Matrix Metalloproteinase 9
1
2009
88
0.320
 Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.320
 Why?
Brachytherapy
9
2014
46
0.320
 Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.320
 Why?
Combined Modality Therapy
11
2010
641
0.320
 Why?
Abdominal Neoplasms
1
2009
15
0.320
 Why?
DNA Repair
11
2007
188
0.310
 Why?
Genome, Human
3
2025
109
0.310
 Why?
Laser Coagulation
1
2009
26
0.310
 Why?
Retrospective Studies
33
2024
6263
0.310
 Why?
Drug Administration Schedule
10
2013
370
0.310
 Why?
Homeodomain Proteins
2
2006
79
0.300
 Why?
Deoxycytidine
4
2006
30
0.300
 Why?
RNA-Binding Proteins
2
2021
118
0.300
 Why?
Protozoan Proteins
1
2008
32
0.300
 Why?
Microsatellite Instability
5
2019
19
0.300
 Why?
Germ-Line Mutation
3
2024
61
0.300
 Why?
Laparoscopy
3
2022
173
0.300
 Why?
Kaplan-Meier Estimate
6
2019
464
0.290
 Why?
Drug Resistance, Neoplasm
6
2016
316
0.290
 Why?
Ovariectomy
7
2010
115
0.280
 Why?
Antigens, CD
2
2007
222
0.280
 Why?
Chromosomes, Human, Pair 3
4
2001
18
0.280
 Why?
SOXC Transcription Factors
2
2019
13
0.270
 Why?
Polymerase Chain Reaction
9
2010
449
0.270
 Why?
Heart Arrest
1
2009
155
0.270
 Why?
Receptors, Estrogen
3
2024
132
0.270
 Why?
Topotecan
5
2013
17
0.270
 Why?
POU Domain Factors
1
2006
1
0.260
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
405
0.260
 Why?
Vulvar Neoplasms
5
2002
58
0.260
 Why?
Neoplasm Metastasis
5
2021
232
0.260
 Why?
HeLa Cells
3
2021
247
0.260
 Why?
Registries
6
2010
563
0.250
 Why?
Anemia
3
2020
67
0.250
 Why?
Genome, Viral
2
2025
79
0.250
 Why?
Survival Rate
10
2009
909
0.250
 Why?
Young Adult
7
2018
4102
0.250
 Why?
Vaginal Smears
6
2006
28
0.240
 Why?
Breast Neoplasms
5
2018
1201
0.240
 Why?
Gene Rearrangement
1
2025
65
0.230
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
572
0.230
 Why?
Chromosome Aberrations
1
2006
280
0.230
 Why?
HSP70 Heat-Shock Proteins
1
2004
60
0.230
 Why?
Receptors, Androgen
1
2024
45
0.220
 Why?
Receptors, Progesterone
1
2024
64
0.220
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.220
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.220
 Why?
Quinazolines
1
2003
32
0.220
 Why?
Oncostatin M
2
2021
5
0.220
 Why?
Antigens, Neoplasm
1
2004
148
0.210
 Why?
Genome-Wide Association Study
2
2017
163
0.210
 Why?
Polymorphism, Genetic
5
2018
180
0.210
 Why?
Small Cell Lung Carcinoma
1
2023
28
0.210
 Why?
Omentum
1
2002
15
0.210
 Why?
Case-Control Studies
7
2019
1156
0.210
 Why?
Chromosome Deletion
3
2000
134
0.200
 Why?
Treatment Outcome
23
2014
5283
0.200
 Why?
Linkage Disequilibrium
3
2017
36
0.200
 Why?
Proto-Oncogene Proteins c-akt
2
2014
156
0.200
 Why?
Neoadjuvant Therapy
2
2022
120
0.200
 Why?
Genetic Variation
4
2019
207
0.200
 Why?
Tumor Microenvironment
2
2021
222
0.200
 Why?
Antibodies, Monoclonal, Humanized
5
2013
226
0.200
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.190
 Why?
CA-125 Antigen
3
2008
16
0.190
 Why?
Base Pair Mismatch
5
2006
22
0.190
 Why?
Chemoradiotherapy
1
2022
42
0.190
 Why?
Suction
1
2001
23
0.190
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.190
 Why?
Postoperative Complications
3
2022
1033
0.190
 Why?
Smoking
1
2005
507
0.190
 Why?
Radiotherapy, Conformal
2
2014
53
0.190
 Why?
Proteins
5
2008
339
0.190
 Why?
Carcinoma in Situ
2
2013
73
0.180
 Why?
Colorectal Neoplasms
3
2002
260
0.180
 Why?
Adaptor Proteins, Signal Transducing
8
2007
198
0.180
 Why?
Antimetabolites, Antineoplastic
2
2002
35
0.180
 Why?
Gene Regulatory Networks
2
2019
106
0.180
 Why?
Fetofetal Transfusion
1
2020
6
0.180
 Why?
Pregnancy, Twin
1
2020
6
0.180
 Why?
Polycythemia
1
2020
9
0.180
 Why?
Minority Groups
1
2022
130
0.180
 Why?
Radiotherapy
3
2010
125
0.180
 Why?
Twins, Monozygotic
1
2020
15
0.180
 Why?
Sarcoma
3
2009
65
0.180
 Why?
Lymph Node Excision
7
2019
131
0.180
 Why?
Genetic Diseases, Inborn
1
2000
20
0.180
 Why?
Transcriptome
2
2020
313
0.180
 Why?
Patient Satisfaction
2
2006
278
0.170
 Why?
Receptor, erbB-3
1
2020
1
0.170
 Why?
Furin
1
2020
3
0.170
 Why?
Phosphoproteins
2
2016
115
0.170
 Why?
HLA-DQ Antigens
1
2000
3
0.170
 Why?
Receptor, IGF Type 1
1
2020
20
0.170
 Why?
Mice, Nude
4
2021
248
0.170
 Why?
Tomography, X-Ray Computed
7
2013
1164
0.170
 Why?
Prenatal Diagnosis
1
2020
97
0.170
 Why?
Tumor Cells, Cultured
7
2021
457
0.170
 Why?
RNA, Neoplasm
3
2007
43
0.170
 Why?
Antibodies, Neoplasm
1
2019
28
0.160
 Why?
Students
1
2022
223
0.160
 Why?
Papillomavirus E7 Proteins
2
2017
31
0.160
 Why?
Adolescent
13
2018
6443
0.160
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
 Why?
Reproducibility of Results
2
2022
1197
0.160
 Why?
Placenta
1
2020
134
0.160
 Why?
Indocyanine Green
1
2019
34
0.150
 Why?
Follow-Up Studies
13
2019
2242
0.150
 Why?
Doxorubicin
4
2009
236
0.150
 Why?
Fallopian Tube Neoplasms
3
2008
14
0.150
 Why?
Decision Making
1
2001
272
0.150
 Why?
Salvage Therapy
3
2008
137
0.150
 Why?
Cyclooxygenase 2
2
2017
43
0.150
 Why?
Sequence Analysis, DNA
1
2019
226
0.150
 Why?
Lung Neoplasms
2
2023
601
0.150
 Why?
Transcription Factors
1
2021
565
0.150
 Why?
HLA-DRB1 Chains
1
2017
5
0.140
 Why?
HLA-B Antigens
1
2017
7
0.140
 Why?
Metabolic Networks and Pathways
1
2018
92
0.140
 Why?
DNA Copy Number Variations
1
2018
109
0.140
 Why?
Proto-Oncogene Proteins
5
2004
145
0.140
 Why?
Receptors, Vitronectin
1
1997
1
0.140
 Why?
Tumor Suppressor Proteins
3
2005
128
0.140
 Why?
Carcinoma, Adenosquamous
3
2009
7
0.140
 Why?
DNA Mutational Analysis
9
2005
175
0.140
 Why?
Bayes Theorem
1
2017
107
0.140
 Why?
Interleukin-10
1
2017
84
0.140
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
17
0.140
 Why?
Adipose Tissue
1
2019
192
0.140
 Why?
In Situ Hybridization
3
2008
66
0.140
 Why?
Leukocytes, Mononuclear
1
2017
118
0.140
 Why?
Protein Binding
1
2019
654
0.140
 Why?
Animals
10
2021
13124
0.140
 Why?
Radiotherapy, Intensity-Modulated
2
2009
177
0.140
 Why?
Gene Expression Regulation, Viral
1
2017
47
0.140
 Why?
Risk Assessment
9
2019
1270
0.140
 Why?
Radiotherapy Dosage
8
2014
248
0.130
 Why?
Body Mass Index
3
2010
677
0.130
 Why?
Radiation Injuries
3
2008
112
0.130
 Why?
Carrier Proteins
7
2006
298
0.130
 Why?
ROC Curve
1
2017
226
0.130
 Why?
Diagnosis, Differential
4
2024
1033
0.130
 Why?
Taxoids
3
2006
37
0.130
 Why?
Biopsy
5
2006
588
0.130
 Why?
Prospective Studies
10
2019
2378
0.130
 Why?
Wound Healing
2
2018
186
0.130
 Why?
Estrogens
1
2017
226
0.130
 Why?
Colposcopy
3
2006
17
0.130
 Why?
Molecular Sequence Data
5
2009
778
0.130
 Why?
Cells, Cultured
2
2017
1571
0.120
 Why?
Mice
6
2021
5687
0.120
 Why?
Carcinosarcoma
3
2019
18
0.120
 Why?
Protein Kinase Inhibitors
2
2014
204
0.120
 Why?
Double-Blind Method
1
2017
708
0.120
 Why?
Apoptosis
2
2021
1097
0.120
 Why?
Sensitivity and Specificity
4
2006
859
0.120
 Why?
Algorithms
1
2019
625
0.120
 Why?
Ultrasonography, Doppler, Color
1
1995
31
0.120
 Why?
Aneurysm
1
1995
33
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1372
0.120
 Why?
Phosphatidylinositol 3-Kinases
2
2014
140
0.120
 Why?
DNA Primers
2
2006
206
0.120
 Why?
Obesity
5
2010
1121
0.120
 Why?
Platinum Compounds
4
2008
11
0.120
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.110
 Why?
Cyclohexanones
1
2014
5
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
 Why?
Embolization, Therapeutic
1
1995
88
0.110
 Why?
Transcriptional Activation
2
2019
119
0.110
 Why?
Camptothecin
3
2010
15
0.110
 Why?
TOR Serine-Threonine Kinases
1
2014
78
0.110
 Why?
Genetic Association Studies
1
2014
119
0.110
 Why?
Paclitaxel
4
2007
84
0.110
 Why?
Introns
1
2013
48
0.110
 Why?
Hypercalcemia
1
1993
33
0.110
 Why?
Decision Support Techniques
2
2010
70
0.110
 Why?
Chromosome Mapping
3
2005
153
0.110
 Why?
Pyridines
1
2014
131
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
181
0.100
 Why?
Brain Neoplasms
1
2016
291
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
34
0.100
 Why?
Keratinocytes
2
2006
77
0.100
 Why?
Models, Genetic
1
2012
172
0.100
 Why?
Tomography, Emission-Computed
4
2005
53
0.100
 Why?
Groin
2
2002
16
0.100
 Why?
RNA, Messenger
4
2021
1089
0.100
 Why?
Glucose
1
2014
341
0.100
 Why?
Laser Therapy
1
1992
83
0.100
 Why?
Cystadenocarcinoma, Serous
2
2024
71
0.100
 Why?
Exons
3
2007
93
0.100
 Why?
Pyrazoles
2
2023
111
0.090
 Why?
Infusions, Intravenous
4
2006
213
0.090
 Why?
Heterozygote
2
2004
83
0.090
 Why?
Condylomata Acuminata
1
1991
4
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1548
0.090
 Why?
Models, Statistical
1
2012
226
0.090
 Why?
Epithelium
2
2007
66
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
19
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Predictive Value of Tests
6
2010
930
0.090
 Why?
Leiomyoma
1
1990
24
0.090
 Why?
Cell Differentiation
2
2009
640
0.090
 Why?
Epigenesis, Genetic
2
2019
372
0.090
 Why?
Polymorphism, Restriction Fragment Length
1
2010
59
0.090
 Why?
Restriction Mapping
3
2006
33
0.090
 Why?
Gastrointestinal Hemorrhage
1
1990
80
0.080
 Why?
Colonic Neoplasms
2
2004
158
0.080
 Why?
Skin Transplantation
1
1990
43
0.080
 Why?
Down-Regulation
4
2020
340
0.080
 Why?
Age Factors
4
2006
1110
0.080
 Why?
Fluorouracil
2
2006
58
0.080
 Why?
Maximum Tolerated Dose
5
2010
39
0.080
 Why?
Endometrium
3
2019
40
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.080
 Why?
Intestinal Diseases
1
2009
26
0.080
 Why?
Lasers, Gas
1
2009
7
0.080
 Why?
Embolism, Air
1
2009
12
0.080
 Why?
Transcription, Genetic
4
2019
361
0.080
 Why?
Lymphatic Vessels
1
2009
53
0.080
 Why?
Vaginal Neoplasms
2
2005
4
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
 Why?
Fluorine Radioisotopes
1
2008
24
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
5
0.080
 Why?
Infertility, Female
1
2008
18
0.080
 Why?
Eimeria
1
2008
3
0.080
 Why?
Haplotypes
2
2017
84
0.080
 Why?
Polyethylene Glycols
2
2006
86
0.080
 Why?
Up-Regulation
2
2020
446
0.080
 Why?
Ubiquitin
1
2008
45
0.080
 Why?
Cell Cycle Proteins
1
2009
161
0.070
 Why?
Cricetinae
1
2008
188
0.070
 Why?
Angiogenesis Inhibitors
2
2006
183
0.070
 Why?
Tumor Burden
2
2021
130
0.070
 Why?
Expressed Sequence Tags
1
2007
8
0.070
 Why?
Infusion Pumps
1
1987
13
0.070
 Why?
Fluorescent Antibody Technique
1
2007
104
0.070
 Why?
Diagnostic Imaging
1
2009
180
0.070
 Why?
Microdissection
1
2007
18
0.070
 Why?
Models, Biological
2
2008
716
0.070
 Why?
Precancerous Conditions
2
2005
82
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Aorta
3
2005
163
0.070
 Why?
Stromal Cells
1
2007
75
0.070
 Why?
Organ Specificity
2
2018
109
0.070
 Why?
Lasers
1
2007
106
0.070
 Why?
Pelvic Floor
1
2007
51
0.070
 Why?
Codon
2
2003
44
0.070
 Why?
RNA, Double-Stranded
1
2006
16
0.070
 Why?
Recombinant Proteins
1
2008
476
0.070
 Why?
Neutropenia
1
2007
116
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.070
 Why?
Tissue Fixation
1
2006
34
0.070
 Why?
Intestinal Perforation
2
2006
23
0.070
 Why?
Specimen Handling
1
2006
55
0.070
 Why?
Pulmonary Embolism
1
1987
99
0.070
 Why?
Protein Kinases
1
2006
71
0.060
 Why?
Head and Neck Neoplasms
2
2016
287
0.060
 Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Proportional Hazards Models
4
2010
415
0.060
 Why?
Abdomen
1
2006
75
0.060
 Why?
Papillomavirus Vaccines
1
2006
67
0.060
 Why?
Recurrence
4
2010
659
0.060
 Why?
Neovascularization, Pathologic
1
2006
155
0.060
 Why?
Probability
4
2007
164
0.060
 Why?
Terminal Care
1
2005
46
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
51
0.060
 Why?
Male
11
2018
25907
0.060
 Why?
Cell Adhesion Molecules
1
2005
86
0.060
 Why?
Quinolines
1
2004
41
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
213
0.060
 Why?
Amyloid
1
2004
30
0.060
 Why?
Tissue Distribution
1
2004
166
0.060
 Why?
Genes, Viral
1
2003
38
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
234
0.050
 Why?
Lactones
1
2003
26
0.050
 Why?
Abdomen, Acute
1
2003
6
0.050
 Why?
RNA, Viral
2
2016
107
0.050
 Why?
Biopsy, Needle
4
2006
178
0.050
 Why?
Thrombospondins
1
2003
8
0.050
 Why?
Obesity, Morbid
1
2004
78
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.050
 Why?
Pyrimidinones
1
2023
19
0.050
 Why?
Fibroma
1
2003
37
0.050
 Why?
Clinical Competence
1
2006
398
0.050
 Why?
Neoplasms, Second Primary
1
2004
74
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
64
0.050
 Why?
Congenital Abnormalities
1
2004
112
0.050
 Why?
Uterine Hemorrhage
1
2002
8
0.050
 Why?
Age of Onset
2
2004
108
0.050
 Why?
PTEN Phosphohydrolase
2
2019
53
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
326
0.050
 Why?
DNA, Ribosomal
1
2002
28
0.050
 Why?
Blood Transfusion, Autologous
1
2002
6
0.050
 Why?
Pregnancy
3
2020
2452
0.050
 Why?
Genital Diseases, Female
1
2002
17
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Medical History Taking
1
2002
48
0.050
 Why?
Medical Records
1
2002
85
0.050
 Why?
Complementary Therapies
1
2002
25
0.050
 Why?
Blood Donors
1
2002
32
0.050
 Why?
Family Health
1
2002
77
0.050
 Why?
AU Rich Elements
1
2021
1
0.050
 Why?
Postmenopause
1
2002
96
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
5
0.050
 Why?
RNA Stability
1
2021
23
0.050
 Why?
Cytokine Receptor gp130
1
2021
13
0.050
 Why?
3' Untranslated Regions
1
2021
52
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
110
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
24
0.050
 Why?
Blotting, Southern
3
2002
41
0.050
 Why?
Xenograft Model Antitumor Assays
1
2021
212
0.040
 Why?
Internship and Residency
1
2006
447
0.040
 Why?
Phosphoric Monoester Hydrolases
1
2000
20
0.040
 Why?
Equipment Design
1
2001
289
0.040
 Why?
Catheterization, Central Venous
1
2001
85
0.040
 Why?
Blood Vessels
1
2001
71
0.040
 Why?
Uganda
1
2020
35
0.040
 Why?
Logistic Models
2
2017
900
0.040
 Why?
Quality Improvement
1
2022
209
0.040
 Why?
Isoenzymes
1
2001
168
0.040
 Why?
Risk Management
1
2000
32
0.040
 Why?
Physical Chromosome Mapping
1
2000
8
0.040
 Why?
Incidence
3
2007
1032
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Patient Discharge
1
2022
321
0.040
 Why?
Interviews as Topic
1
2001
272
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
 Why?
Cell Survival
1
2021
589
0.040
 Why?
DNA Repair Enzymes
1
1999
43
0.040
 Why?
Adenosine Triphosphatases
1
1999
87
0.040
 Why?
Cell Nucleus
1
2019
182
0.040
 Why?
Pregnancy Outcome
1
2020
207
0.040
 Why?
Regression Analysis
3
2006
382
0.040
 Why?
Cross-Sectional Studies
1
2024
1610
0.040
 Why?
Molecular Targeted Therapy
1
2019
123
0.040
 Why?
Coloring Agents
1
2019
66
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Gene Dosage
1
2018
74
0.040
 Why?
Histone Demethylases
1
2018
17
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Leptin
1
2019
143
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
51
0.040
 Why?
Major Histocompatibility Complex
1
2017
12
0.040
 Why?
Estradiol
1
2019
221
0.040
 Why?
Databases, Genetic
1
2018
88
0.040
 Why?
Genotyping Techniques
1
2017
20
0.040
 Why?
Child
4
2018
6906
0.040
 Why?
Chemokines
1
2017
75
0.040
 Why?
Mass Screening
1
2000
344
0.040
 Why?
Receptors, Collagen
1
1997
3
0.040
 Why?
Receptors, Fibronectin
1
1997
5
0.040
 Why?
Time Factors
4
2010
2935
0.040
 Why?
Coculture Techniques
1
2017
142
0.040
 Why?
Transforming Growth Factor beta
1
2018
136
0.040
 Why?
Interferon-gamma
1
2018
177
0.040
 Why?
Integrins
1
1997
30
0.030
 Why?
Chemotherapy, Adjuvant
2
2010
121
0.030
 Why?
Diet, High-Fat
1
2019
214
0.030
 Why?
Quality-Adjusted Life Years
2
2010
63
0.030
 Why?
Epithelial Cells
2
2006
207
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
735
0.030
 Why?
Herpesviridae
1
2016
17
0.030
 Why?
Viruses
1
2016
22
0.030
 Why?
Host-Pathogen Interactions
1
2017
135
0.030
 Why?
Mice, Transgenic
1
2017
540
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
40
0.030
 Why?
DNA Replication
1
1997
156
0.030
 Why?
Cost-Benefit Analysis
2
2010
266
0.030
 Why?
Plasmids
2
2001
164
0.030
 Why?
Sequence Analysis, RNA
1
2016
88
0.030
 Why?
Central Nervous System Neoplasms
1
2016
63
0.030
 Why?
Fibroblasts
1
2017
336
0.030
 Why?
Electrosurgery
1
1995
8
0.030
 Why?
Macrophages
1
2018
364
0.030
 Why?
Prostatic Neoplasms
1
1998
384
0.030
 Why?
CpG Islands
2
2008
108
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Arteries
1
1995
91
0.030
 Why?
Computational Biology
1
2016
215
0.030
 Why?
Cytokines
1
2017
606
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Multivariate Analysis
2
2009
583
0.030
 Why?
Treatment Failure
2
2008
118
0.030
 Why?
Missouri
2
2006
64
0.030
 Why?
Organs at Risk
1
2014
71
0.030
 Why?
Inclusion Bodies
1
1993
18
0.030
 Why?
Cell Division
2
1994
291
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
22
0.030
 Why?
Cell Death
1
2014
175
0.030
 Why?
Imaging, Three-Dimensional
1
2014
150
0.030
 Why?
Risk
2
2004
324
0.030
 Why?
Skin Physiological Phenomena
1
1992
12
0.030
 Why?
Epidermis
1
1992
23
0.030
 Why?
Guinea Pigs
1
1992
75
0.030
 Why?
Pelvis
2
2004
66
0.030
 Why?
Regeneration
1
1992
58
0.020
 Why?
Pedigree
2
2004
119
0.020
 Why?
Deoxyglucose
1
2012
36
0.020
 Why?
Colectomy
1
1992
37
0.020
 Why?
Computer Simulation
1
2012
279
0.020
 Why?
Pilot Projects
2
2004
698
0.020
 Why?
Sequence Deletion
2
2003
67
0.020
 Why?
Premenopause
1
2010
26
0.020
 Why?
Amino Acid Sequence
2
2003
574
0.020
 Why?
Staurosporine
1
2010
12
0.020
 Why?
Anastomosis, Surgical
1
1990
66
0.020
 Why?
Remission Induction
1
2010
208
0.020
 Why?
Molecular Weight
1
1990
82
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
67
0.020
 Why?
ras Proteins
2
2001
64
0.020
 Why?
Cicatrix
1
1990
40
0.020
 Why?
Staining and Labeling
1
1990
96
0.020
 Why?
Hemoglobins
1
1990
109
0.020
 Why?
Chi-Square Distribution
1
2010
277
0.020
 Why?
Perioperative Care
1
2009
42
0.020
 Why?
Fetus
1
1990
183
0.020
 Why?
Urinary Incontinence
1
2009
38
0.020
 Why?
Gene Knockdown Techniques
1
2009
105
0.020
 Why?
Organoplatinum Compounds
1
2008
14
0.020
 Why?
Vinblastine
1
2008
22
0.020
 Why?
Life Style
1
2009
144
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
183
0.020
 Why?
Emotions
1
2009
168
0.020
 Why?
Cell Line
1
1990
988
0.020
 Why?
Skin
1
1990
388
0.020
 Why?
Cadherins
1
2007
63
0.020
 Why?
Demography
1
2007
94
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
135
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
DNA Mismatch Repair
1
2006
16
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
15
0.020
 Why?
NIH 3T3 Cells
1
2006
51
0.020
 Why?
Immunoenzyme Techniques
2
2001
137
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
160
0.020
 Why?
Cryopreservation
1
2006
33
0.020
 Why?
Analysis of Variance
1
2007
552
0.020
 Why?
Transfection
1
2006
356
0.020
 Why?
Mutation, Missense
1
2006
103
0.020
 Why?
Gene Expression
1
2008
610
0.020
 Why?
Nurse Practitioners
1
2006
42
0.020
 Why?
Gynecology
1
2006
48
0.020
 Why?
Early Diagnosis
1
2006
88
0.020
 Why?
Medical Futility
1
2005
8
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Cyclophosphamide
1
2006
168
0.020
 Why?
Triage
1
2006
60
0.020
 Why?
Leiomyosarcoma
1
2005
20
0.020
 Why?
Hospice Care
1
2005
26
0.020
 Why?
Cytodiagnosis
1
2005
41
0.020
 Why?
Health Services
1
2005
65
0.020
 Why?
Phosphorylation
1
2006
525
0.020
 Why?
Obstetrics
1
2006
84
0.020
 Why?
Lymphatic System
1
2004
13
0.010
 Why?
Penetrance
1
2004
6
0.010
 Why?
Area Under Curve
1
2004
179
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
75
0.010
 Why?
Calcification, Physiologic
1
2004
40
0.010
 Why?
Laparotomy
1
2004
35
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
16
0.010
 Why?
Ethanol
1
2006
336
0.010
 Why?
Genomic Instability
1
2004
90
0.010
 Why?
Tamoxifen
1
2004
60
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Genes, p16
1
2003
8
0.010
 Why?
Confidence Intervals
1
2003
154
0.010
 Why?
Codon, Terminator
1
2003
5
0.010
 Why?
Administration, Oral
1
2004
434
0.010
 Why?
Frameshift Mutation
1
2003
16
0.010
 Why?
Liposomes
1
2003
52
0.010
 Why?
Mutagenesis, Insertional
1
2003
22
0.010
 Why?
Palliative Care
1
2005
190
0.010
 Why?
Body Weight
1
2005
517
0.010
 Why?
Cytoskeletal Proteins
1
2003
47
0.010
 Why?
DNA Transposable Elements
1
2003
103
0.010
 Why?
Physicians
1
2006
232
0.010
 Why?
Prevalence
1
2006
971
0.010
 Why?
Reference Values
1
2003
307
0.010
 Why?
beta Catenin
1
2003
97
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
19
0.010
 Why?
Ifosfamide
1
2002
11
0.010
 Why?
Documentation
1
2002
33
0.010
 Why?
Trans-Activators
1
2003
134
0.010
 Why?
Bleomycin
1
2002
34
0.010
 Why?
Hospitals, University
1
2002
77
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
73
0.010
 Why?
Age Distribution
1
2002
170
0.010
 Why?
Equipment Failure
1
2001
63
0.010
 Why?
Statistics, Nonparametric
1
2002
192
0.010
 Why?
Nucleic Acid Hybridization
2
1991
55
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
77
0.010
 Why?
Carcinoma, Small Cell
1
2001
25
0.010
 Why?
Genes, erbB-1
1
2001
8
0.010
 Why?
Radiography
1
2002
485
0.010
 Why?
Outpatients
1
2002
117
0.010
 Why?
Hospitalization
1
2005
675
0.010
 Why?
DNA
1
2004
535
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
95
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
155
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
21
0.010
 Why?
Morbidity
1
2000
130
0.010
 Why?
Blotting, Western
1
2001
578
0.010
 Why?
Gene Deletion
1
2000
261
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
154
0.010
 Why?
Chromosomes, Bacterial
1
1998
14
0.010
 Why?
Cloning, Molecular
1
1998
190
0.010
 Why?
Infant
1
2006
3628
0.010
 Why?
Child, Preschool
1
2006
3942
0.010
 Why?
Drug Resistance, Multiple
1
1997
24
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
66
0.010
 Why?
Gene Frequency
1
1997
97
0.010
 Why?
United States
1
2007
4955
0.010
 Why?
Dimethyl Sulfoxide
1
1994
13
0.010
 Why?
Glycerol
1
1994
15
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
131
0.010
 Why?
Drug Carriers
1
1994
70
0.010
 Why?
Cell Cycle
1
1994
226
0.010
 Why?
Retroperitoneal Space
1
1991
27
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (633) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department